BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37963436)

  • 1. Tumor lysis syndrome is associated with worse outcomes in adult patients with acute lymphoblastic leukemia.
    Rios-Olais FA; Gil-Lopez F; Mora-Cañas A; Demichelis-Gómez R
    Acta Haematol; 2023 Nov; ():. PubMed ID: 37963436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
    Montesinos P; Lorenzo I; Martín G; Sanz J; Pérez-Sirvent ML; Martínez D; Ortí G; Algarra L; Martínez J; Moscardó F; de la Rubia J; Jarque I; Sanz G; Sanz MA
    Haematologica; 2008 Jan; 93(1):67-74. PubMed ID: 18166787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome.
    Truong TH; Beyene J; Hitzler J; Abla O; Maloney AM; Weitzman S; Sung L
    Cancer; 2007 Oct; 110(8):1832-9. PubMed ID: 17724682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of tumor lysis syndrome in 380 cases of acute leukemia].
    Zhang Q; Liu KQ; Liu BC; Zhou CL; Li W; Lin D; Wang Y; Mi YC; Wang JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):61-4. PubMed ID: 25687047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemia.
    Xue Y; Chen J; Gao S; Zhai X; Wang N; Gao J; Lv Y; Yin M; Zhuang Y; Zhang H; Zhu X; Wu X; Li CK; Hu S; Liang C; Jin R; Jiang H; Yang M; Sun L; Pan K; Cai J; Tang J; Guan X; Fang Y
    Sci Rep; 2021 May; 11(1):9656. PubMed ID: 33958615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Lysis Syndrome and Hyperleukocytosis in Childhood Acute Lymphoblastic Leukemia in a Tertiary Care Hospital.
    Tasmeen R; Islam A; Alam ST; Begum M
    Mymensingh Med J; 2017 Oct; 26(4):906-912. PubMed ID: 29208883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era.
    Toda Y; Ashizawa M; Murahashi R; Nakashima H; Ikeda T; Kawaguchi SI; Nagayama T; Umino K; Minakata D; Morita K; Yamamoto C; Hatano K; Sato K; Fujiwara SI; Ohmine K; Kanda Y
    Int J Hematol; 2024 Jun; 119(6):660-666. PubMed ID: 38575822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin's lymphoma and acute lymphoblastic leukemia.
    Sevinir B; Demirkaya M; Baytan B; Güneş AM
    Turk J Haematol; 2011 Mar; 28(1):52-9. PubMed ID: 27263942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The analysis of the risks for the development of tumour lysis syndrome in children.
    Kopecna L; Dolezel Z; Osvaldova Z; Starha J; Hrstkova H
    Bratisl Lek Listy; 2002; 103(6):206-9. PubMed ID: 12448566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of tumor lysis syndrome in childhood acute lymphoblastic leukemia based on machine learning models: a retrospective study.
    Xiao Y; Xiao L; Zhang Y; Xu X; Guan X; Guo Y; Shen Y; Lei X; Dou Y; Yu J
    Front Oncol; 2024; 14():1337295. PubMed ID: 38515564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
    Baeksgaard L; Sørensen JB
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-asparginase administration reduces white blood cell count and prevents tumor lysis syndrome in children with hyperleukocytic acute lymphoblastic leukemia.
    Sondhi V; Sharma A; Taneja M; Arora B; Banavali SD
    Acta Haematol; 2015; 133(1):6-9. PubMed ID: 24968963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration.
    Saccente SL; Kohaut EC; Berkow RL
    Pediatr Nephrol; 1995 Oct; 9(5):569-73. PubMed ID: 8580012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myeloma.
    Zhang Q; Zu C; Jing R; Feng Y; Zhang Y; Zhang M; Lv Y; Cui J; Zhou L; Meng Y; Wang L; Cen Z; Chang AH; Hu Y; Huang H
    Front Immunol; 2023; 14():1125357. PubMed ID: 37215107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of continuous kidney replacement therapy for managing tumor lysis syndrome in children with hematologic malignancies.
    Anderson A; Shoulders L; James V; Ashcraft E; Cheng C; Ribeiro R; Elbahlawan L
    Front Oncol; 2023; 13():1234677. PubMed ID: 37664024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A predictive model for the detection of tumor lysis syndrome during AML induction therapy.
    Mato AR; Riccio BE; Qin L; Heitjan DF; Carroll M; Loren A; Porter DL; Perl A; Stadtmauer E; Tsai D; Gewirtz A; Luger SM
    Leuk Lymphoma; 2006 May; 47(5):877-83. PubMed ID: 16753873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily serum phosphate increase as early and reliable indicator of kidney injury in children with leukemia and lymphoma developing tumor lysis syndrome.
    Biró E; Erdélyi D; Varga P; Sinkó M; Bartyik K; Kovács G; Ottóffy G; Vincze F; Szegedi I; Kiss C; Szabó T
    Pediatr Nephrol; 2023 Sep; 38(9):3117-3127. PubMed ID: 36943467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-based management strategy and outcomes of tumor lysis syndrome in children with leukemia/lymphoma: Analysis from a resource-limited setting.
    Gopakumar KG; Seetharam S; Km JK; Nair M; Rajeswari B; Cs G; Vr P; Thankamony P
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27401. PubMed ID: 30101454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic burden of tumor lysis syndrome among patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world US retrospective study.
    Rogers KA; Lu X; Emond B; Côté-Sergent A; Kinkead F; Lafeuille MH; Lefebvre P; Huang Q
    J Manag Care Spec Pharm; 2022 Sep; 28(9):1033-1045. PubMed ID: 35816124
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique.
    Darmon M; Vincent F; Camous L; Canet E; Bonmati C; Braun T; Caillot D; Cornillon J; Dimicoli S; Etienne A; Galicier L; Garnier A; Girault S; Hunault-Berger M; Marolleau JP; Moreau P; Raffoux E; Recher C; Thiebaud A; Thieblemont C; Azoulay E;
    Br J Haematol; 2013 Aug; 162(4):489-97. PubMed ID: 23772757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.